STEP Program for Low Libido
(STEP for SDD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new online program called STEP, designed to help couples with differing levels of sexual desire, which can cause relationship distress. The study will test two versions of the program: STEP-NT, which includes therapist support, and STEP-T, which couples complete independently, comparing them to a waitlist group. The goal is to evaluate the effectiveness of each version and assess couples' satisfaction with the program. Couples who have been together for at least a year and experience distress due to differing sexual desires may be suitable for this trial. As an unphased trial, it offers couples the chance to explore innovative solutions for improving relationship dynamics.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. However, you must not start any new treatment for low libido during the study.
What prior data suggests that the STEP program is safe for couples with sexual desire discrepancy?
Research shows that the STEP program, whether done independently (STEP-NT) or with a therapist (STEP-T), is generally manageable. Studies have found that online programs designed to enhance sexual desire often improve sexual satisfaction and reduce distress, without major negative effects. For instance, past trials demonstrated improvements in sexual desire and reduced distress without causing harm. Similar programs have reported no serious side effects. Since this trial is not in its early stages, previous research provides a strong expectation of safety.12345
Why are researchers excited about this trial?
Researchers are excited about the STEP Program for low libido because it offers a unique approach by providing two different methods of intervention: one with therapist guidance (STEP-T) and one without (STEP-NT). Unlike traditional treatments, which often involve medication or hormone therapy, these methods focus on behavioral and psychological strategies to enhance libido. The therapist-guided option, STEP-T, may offer personalized support, potentially leading to better outcomes for participants. Meanwhile, STEP-NT allows individuals the flexibility to self-guide through the program, which could be appealing for those seeking more autonomy in their treatment. Overall, this trial could revolutionize how low libido is addressed by providing more tailored and accessible options.
What evidence suggests that the STEP program is effective for sexual desire discrepancy?
Research has shown that the STEP program can assist couples with differing levels of sexual desire, known as sexual desire discrepancy (SDD). In a previous study, about 49% of participants experienced noticeable improvement, while 37% to 42% had significant reductions in sexual distress. The program incorporates techniques from cognitive-behavioral therapy and mindfulness, which have successfully boosted sexual desire and eased distress in similar cases. In this trial, participants will join either the self-guided version (STEP-NT) or the therapist-guided version (STEP-T), both of which have demonstrated potential benefits. Participants often report significant improvements in desire and relationship satisfaction, making STEP a promising option for managing SDD.16789
Who Is on the Research Team?
Lori A Brotto
Principal Investigator
University of British Columbia
Are You a Good Fit for This Trial?
This trial is for couples experiencing Sexual Desire Discrepancy (SDD), where one partner has a significantly lower level of sexual desire causing distress. Couples must be willing to engage with an online program and provide feedback.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive an 8-week online intervention (STEP) designed to reduce distress related to sexual desire discrepancy, with two formats: therapist-guided (STEP-T) and self-guided (STEP-NT).
Waitlist Control
Participants in the waitlist control group do not receive any treatment for 10 weeks before being re-randomized to either STEP-T or STEP-NT.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 2-4 weeks post-treatment and at 6-month follow-up.
What Are the Treatments Tested in This Trial?
Interventions
- STEP-NT
- STEP-T
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor